Floyd F. Petersen - 18 May 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
18 May 2022
Net transactions value
-$647
Form type
4
Filing time
19 May 2022, 17:58:51 UTC
Previous filing
03 May 2022
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $347,179 +20,291 +27% $17.11 96,369 18 May 2022 Direct
transaction AMPH Common Stock Sale $347,826 -9,924 -10% $35.05 86,445 18 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -20,291 -100% $0.000000* 0 18 May 2022 Common Stock 20,291 $17.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0432 to $35.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.